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1. Introduction 
Free-living amoebae (FLA) belonging to Acanthamoeba and Sappinia genera as well as 
Balamuthia mandrillaris and Naegleria fowleri species are aerobic, mitochondriate, eukaryotic 
protists that occur worldwide and can potentially cause infections in humans and other 
animals (Visvesvara and Maguire, 2006; Visvesvara et al., 2007). Due to the fact that these 
amoebae have the ability to exist as free-living organisms in nature and only occasionally 
invade a host and live as parasites within host tissue, they have also been called amphizoic 
amoebae (Page, 1988).  
All four amoebae are known so far to cause infections of the central nervous system (CNS). 
Several species of Acanthamoeba (i.e. A. castellanii, A. culbertsoni, A. hatchetti, A. polyphaga, A. 
rhysodes), the only known species of Balamuthia, B. mandrillaris, two species of Sappinia 
genus, S. diploidea and S.pedata, and only one species of Naegleria, N. fowleri, are known to 
cause disease in humans and other animals (Khan, 2006; Visvesvara et al., 2007).  
 
 
  
Fig. 1. Trophozoite (right) and Cyst stages (left) in Acanthamoeba sp. 
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2. Central nervous systems infections due to free living amoebae 
The waterborne disease Primary Amoebic Meningoencephalitis (PAM) was discovered in 
Australia in the 1960s. Since then, it has been reported from about 15 other countries in 
Africa, Asia, Europe and North and South America. PAM is caused by Naegleria fowleri, and 
follows intranasal infection during swimming in warm, contaminated freshwater. Most 
victims have been children or young adults and the disease is almost invariably fatal. 
Infections have been linked with warm waters such as above-ground pipelines, tropical 
lakes, geothermal water, heated swimming pools or discharges of industrial cooling water. 
Until recent cases in the USA were identified, Australia was the only country where 
Naegleria fowleri has been associated with public water supplies (Visvesvara et al., 2007; 
Heggie, 2010). Recently, the causal agent of a PAM case in the US was diagnosed as 
Paravahlkampfia francinae n. sp., a new species of the free-living amoeba genus 
Paravahlkampfia that was isolated from the cerebrospinal fluid of a patient with headache, 
sore throat, and vomiting, presenting typical symptoms of PAM caused by Naegleria fowleri. 
Thus awareness of novel emerging amoebae as causative agents of PAM should also be 
considered (Visvesvara et al., 2009). 
PAM should be suspected in young adults and children with acute neurological symptoms 
as described below and recent exposure to fresh water. The time from initial contact 
(swimming, diving, water skiing, or simply immersing head in water) to onset of illness is 
usually 5–7 days, and may even be as short at 24 h. Because there are no distinctive clinical 
features that differentiate PAM from acute pyogenic or bacterial meningoencephalitis it is 
imperative that the attending physician obtains information regarding the patient's contact 
with fresh water, including hot springs, during the past week. The earliest symptoms are 
sudden appeareance of headaches, high temperature, nuchal rigidity, followed by nausea, 
vomiting, irritability and restlessness. Nuchal rigidity usually occurs with positive Kernig 
and Brudzinski signs. Photophobia may occur late in the clinical course, followed by 
neurological abnormalities, including lethargy, seizures, confusion, coma, diplopia or 
bizarre behaviour, leading to death within a week. Cranial nerve palsies (third, fourth, and 
sixth cranial nerves) may indicate brain edema and herniation. Intracranial pressure is 
usually raised to 600 mm H2O or higher. Cardiac rhythm abnormalities and myocardial 
necrosis have been found in some cases (Martinez, 1980; Visvesvara et al., 2007). 
CSF may vary in colour from greyish to yellowish-white, and may be tinged red with a few 
red cells (250 mm−3) in the early stages of disease. However, as the disease progresses the 
red blood cell number increases to as high as 24.600 mm−3. The white blood cell count, 
predominantly polymorphonuclear leukocytes (PMN), also may vary from 300 cells mm−3 to 
as high as 26000 mm−3. No bacteria are seen. The CSF pressure is usually elevated (300–600 
mm H2O). The protein concentration may range from 100 mg per 100 ml to 1000 mg per 100 
ml, and glucose may be 10 mg/100 mL or lower (Martinez, 1980; Visvesvara & Maguire, 
2006; Visvesvara et al., 2007). The cause of death is usually increased intracranial pressure 
with brain herniation, leading to cardiopulmonary arrest and pulmonary edema (Martinez, 
1980; Visvesvara & Maguire, 2006; Visvesvara et al., 2007). 
Many species of Acanthamoeba can cause Granulomatous Amoebic Encephalitis (GAE) also 
known as Acanthamoeba Granulomatous Encephalitis (AGE) (Khan, 2006; da Rocha-Azevedo 
et al., 2009), is a rare, chronic, progressive infection of the CNS that may involve the lungs 
(da Rocha-Azevedo et al., 2009). AGE is usually associated with an underlying debilitating 
disease or immune suppressed individuals including HIV-AIDS patients, diabetics, 
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individuals undergoing organ transplants or cancer chemotherapy, and drug abusers (Khan, 
2006; Visvesvara et al., 2007; da Rocha-Azevedo et al., 2009). 
Therefore, the onset of AGE is slow and subtle and develops as a chronic disease from 
several weeks to months (Visvesvara & Maguire, 2006, Visvesvara et al. 2007). The usual 
features of AGE consist of headache, stiff neck, and mental-state abnormalities, as well as 
nausea, vomiting, low-grade fever, lethargy, cerebellar ataxia, visual disturbances, 
hemiparesis, seizures and coma. Facial palsy with numbness resulting in facial asymmetry is 
often seen. Cerebral hemispheres are usually the most heavily affected CNS tissue. They are 
often edematous, with extensive hemorrhagic necrosis involving the temporal, parietal, and 
occipital lobes. Computerized tomography (CT) scans of the brain show large, low-density 
abnormalities mimicking a single or multiple space-occupying mass. Magnetic resonance 
imaging (MRI) with enhancements shows multiple, ring-enhancing lesions in the brain 
(Seijo-Martínez et al., 2000; Shirwadkar et al. 2006; Visvesvara et al., 2007).  
Acanthamoebae infecting the CNS are not readily found in the cerebrospinal fluid (CSF), 
although they have been isolated from the CSF in a few cases. Acanthamoeba that had 
apparently entered from the nasopharynx through a fistula have been detected in the CSF of 
a patient without CNS disease (Petry et al., 2006). CSF examination in general reveals 
lymphocytic pleocytosis with mild elevation of protein and normal or slightly depressed 
glucose. Examination of the autopsied brain reveals cerebral edema, areas of cortical and 
basal ganglia softening, and multiple necrotic and hemorrhagic areas of CNS tissues. The 
brainstem, cerebral hemispheres and cerebellum may show areas of hemorrhagic infarcts. 
Histological examination reveals the presence of multinucleated giant cells in the cerebral 
hemispheres, brain stem, mid-brain, cerebellum, and basal ganglion. Necrotic tissue with 
lipid-containing macrophages and neovascularization suggesting a tumour is often seen. 
Trophozoites and cysts of acanthamoebae are usually spread all over the infected tissue. 
Many blood vessels are thrombotic with fibrinoid necrosis and cuffed by 
polymorphonuclear leukocytes, amoebic trophozoites, and cysts. Multinucleated giant cells 
forming granulomas may be seen in immunocompetent patients but less often in 
immunocompromised patients.  
Some infected individuals, mostly with HIV/AIDS, develop chronic ulcerative skin lesions, 
abscesses, or erythematous nodules (Seijo-Martínez et al., 2000; Visvesvara & Maguire, 2006, 
Visvesvara et al., 2007), especially of the chest and limbs. These nodules are usually solid 
but sometimes they become ulcerated and purulent. The prodromal period is unknown and 
several weeks or months may elapse following infection before the disease becomes 
apparent. Because of the time delay, the precise portal of entry is not clearly known, but the 
wide dissemination of these amoebae in the environment allows for many possible contacts 
and modes of infection. Trophic amoebae and/or cysts of Acanthamoeba have been isolated 
from the nasal mucosa of healthy individuals, suggesting a nasopharyngeal route as one 
means of invasion. Amoebae may also enter the body through ulcers in the skin, resulting in 
hematogenous dissemination to the lungs and brain, or by inhalation of amoebic cysts 
(Visvesvara & Maguire, 2006; Visvesvara et al 2007).  
In addition to causing CNS infections, Acanthamoeba also causes a vision-threatening 
disease, Acanthamoeba keratitis (AK) which mostly affects contact lens wearers although 
many cases have been reported worldwide in non contact lens users mostly related to a 
previous corneal trauma [6, 7, 8]. The number of affected individuals is increasing 
worldwide. Morever, recent outbreaks of Acanthamoeba keratitis have been recently reported 
in the United States and Australia (Verani et al., 2009; Tu and Joslin, 2010; Patel et al., 2010; 
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Joslin et al., 2010). AK is an acute, painful infection that can occur in immunocompetent 
individuals. When AK is not treated promptly, loss of visual acuity and blindness can occur 
[6, 7, 8]. Initial symptoms of AK are not specific and include disproportional eye pain, 
photophobia, eye redness, and tearing, usually affecting one eye. Using a slit-lamp, corneal 
inflammation leading to formation of a ring-like stromal infiltrate can be observed. 
Furthermore, corneal epithelial erosion, irregularities, and edema are present. The radial 
perineural distribution of the infiltrate (radial keratoneuritis) is characteristic for AK, similar 
to the type of infiltration observed in Pseudomonas aeruginosa keratitis. Later stages of 
infection can result in epithelial denudation and stromal necrosis. Contact lens usage 
and/or incidents of corneal trauma are strong indicators for AK. Despite the clinical picture, 
AK is often misdiagnosed as herpes or bacterial keratitides which present similar clinical 
symptomatology (Khan, 2006; Visvesvara et al., 2007; Martín-Navarro et al., 2008; da Rocha-
Azevedo et al., 2009).  
Both Acanthamoeba and Balamuthia cause infections of the lungs and skin (Khan, 2006; 
Maciver, 2007; Visvesvara et al., 2007; da Rocha-Azevedo et al., 2009). More recently, 
Balamuthia mandrillaris, has been discovered to cause a fatal encephalitis in humans 
(Maciver, 2007; Visvesvara et al., 2007; Matin et al., 2008). This encephalitis is known as 
Balamuthia amoebic encephalitis (BAE). There are worrying features of BAE that are 
emerging, even compared to AGE and PAM. PAM is restricted to bodies of warm 
freshwater, such as swimming pools and lakes, and so can be avoided after its presence has 
been identified.  
AGE is mostly a disease of the immunocompromised, and so affects a small subpopulation 
of individuals who could conceivably be monitored for early signs of AGE; for example, by 
inspection of cerebrospinal fluid (CSF) (Deetz et al., 2003; Maciver, 2007). Present data 
indicate that BAE is more difficult to detect, as it is sporadic, affecting both 
immunocompromised and immunocompetent, otherwise healthy, individuals with little 
evidence of predisposing factors (i.e. working in farms or soil related environments. The 
unpredictable nature of the disease may mean that BAE is even less likely to be diagnosed in 
time for medical intervention and, like AGE and PAM, it is essential for BAE to be 
diagnosed early if it is to be treated successfully (Deetz et al., 2003; Petry et al., 2006; 
Maciver, 2007]. Worryingly, BAE may be relatively a common type of amoebic encephalitis 
and some cases reported to be due to Acanthamoeba have subsequently been shown to be due 
to B. mandrillaris (Deetz et al., 2003; Maciver, 2007).  
Recently, Sappinia diploidea and Sappinia pedata species, also belonging to the free-living 
amoeba group, that normally live in soil contaminated with faeces of elk, bison, and cattle, 
have been identified as causing encephalitis in an otherwise healthy individuals (Gelman et 
al., 2001; Qvarstrom et al., 2009; Walochnik et al., 2010), indicating that there are probably 
other amoebae that are capable of causing encephalitis in humans.  
A study looking at causes of encephalitis found at least 13. 939 cases of acute encephalitis 
diagnosed between 1990 and 1999 in California [13, 26]. Amongst these cases, 0.1% was 
attributed to Naegleria, 0.63% to other protozoans, and 34.7% were from unspecified causes. 
The California Encephalitis Project (CEP) (reviewed in Maciver et al., 2007), identified three 
fatal cases caused by Balamuthia from the 334 patients who met the criteria for CEP. No cases of 
encephalitis caused by either Acanthamoeba or Naegleria were seen but immunocompromised 
patients were excluded from the study [30]. Thus, these data would suggest that in California 
in the 1990s Balamuthia and Naegleria each accounted for approximately 0.1% of total 
encephalitis cases in these studies (reviewed in Maciver et al., 2007).  
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3. Therapy and prognosis of FLA infections 
3.1 Acanthamoeba spp. 
Treatment of AGE is problematic because of the lack of clear-cut symptoms, the lack of a 
good reliable diagnostic test, and the fact that diagnosis is often made postmortem. 
However, several patients with GAE caused by Acanthamoeba spp., as well as some with 
Acanthamoeba cutaneous infection without CNS involvement, have been successfully treated 
with a combination of pentamidine isethionate, sulfadiazine, flucytosine, and fluconazole or 
itraconazole. For Acanthamoeba cutaneous infection without CNS involvement, topical 
applications of chlorhexidine gluconate and ketoconazole cream in addition to the above-
noted antimicrobials have resulted in therapeutic success. In many cases, however, therapy 
had to be discontinued because of undesirable side effects of the medications Visvesvara et 
al., 2007. A combination of factors –late diagnosis, suboptimal efficacy of antimicrobial 
therapy, and problems inherent to the immunocompromised host –make for a poor 
prognosis for GAE patients. 
Treatment of Acanthamoeba keratitis has been fairly successful. A variety of drugs have 
been used, including chlorhexidine, polyhexamethylene biguanide, propamidine 
isethionate, dibromopropamidine isethionate, neomycin, paromomycin, polymyxin B, 
clotrimazole, ketoconazole, miconazole, and itraconazole (Visvesvara et al., 2007; da Rocha-
Azevedo, 2009). Brolene, a commercially available eye medication (in the UK, and other EU 
countries) containing propamidine isethionate and dibromopropamidine isethionate, was 
found to be effective in the treatment of Acanthamoeba infections but may be accompanied by 
drug toxicity and development of resistance. 
A number of compounds, including a variety of diamidine compounds, synthetic maganins 
combined with silver nitrate, imidazole and triazole compounds, azithromycin, 
phenothiazines and povidone-iodine have been screened in vitro for efficacy against 
Acanthamoeba spp. Another drug, miltefosine, an alkylphospholipid, has also been shown to 
have amoebicidal potential. Significantly, medical cure has been achieved with the 
application of either polyhexamethylene biguanide (PHMB) or chlorhexidine gluconate with 
or without Brolene. When medical treatment failed, a combination of debridement and 
penetrating keratoplasty has been used with good results in some cases. Currently, the 
drugs of for AK are chlorhexidine gluconate, PHMB and Brolene, and they have greatly 
improved the prognosis for AK sufferers (reviewed in Visvesvara et al., 2007). However, it 
was recently demonstrated that clinical strains of Acanthamoeba are resistant to the 
concentrations of chlorhexidine gluconate or PHMB present in contact lens 
maintenance/disinfection solutions (Martín-Navarro et al., 2008). Thus, the latter together 
with the demonstrated toxicity of these molecules is supporting the need for novel therapies 
to treat AK worldwide. 
3.2 Balamuthia mandrillaris  
Balamuthia amoebic encephalitis (BAE) is a rare, subacute to chronic disease that is 
characterized by hemorrhagic necrotizing lesions or brain abscess (normally detected by 
neuroimaging scans) with severe meningeal irritation and encephalitis. The lesions are 
mainly detected in the basal ganglia, midbrain, brainstem and cerebral hemiparesis with 
characteristic lesions in the CNS parenchyma. Typically, encephalitis is of the 
granulomatous type composed of the amoebae, CD4 and CD8 T cells, B lymphocytes, few 
plasma cells, macrophages and multinucleate giant cells (Martinez and Visvesvara, 1997; 
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2001; Matin et al., 2008). However, in immunocompromised patients with an impaired 
cellular immune response, granuloma formation may be minimal or absent (Martinez and 
Visvesvara, 1997; 2001).  
Post mortem examination often shows severe edema and hemorrhagic necrosis. The amoebae 
colonize the brain tissue and produce subacute necrotising hemorrhagic encephalitis leading 
to brain dysfunction. Balamuthia mandrillaris trophozoites and cysts are present within the 
perivascular spaces and within the necrotic CNS parenchyma (Martinez and Visvesvara, 1997). 
The disease is likely to take a cutaneous route before secondarily attacking the CNS. The time 
period of transition from the cutaneous form to the CNS ranges from 30 days to 2 years, with 
an average of 5 –8 months (Bravo and Sanchez, 2003). The skin lesions may appear at the site 
of an abrasion of the skin surface of the patient, or lesions can appear as single or multiple 
plaques or nodules (Deetz et al., 2003). These plaques may appear on the face, the trunk or the 
limbs, with a rubbery to hard consistency (Bravo and Sanchez, 2003). Skin lesions indicate a 
site of entry and are frequently observed in BAE patients. 
Because most of the cases of BAE have presented with no clear-cut clinical profile, they have 
been treated empirically with steroids as well as with antibacterial, antifungal and antiviral 
agents with almost no effect upon the course of the infection. Anti-inflammatory steroids 
that were administered may have actually facilitated spread of the infection by suppressing 
the inflammatory response. Two patients from California, a 60-year-old man, and a 6-year 
old girl, in addition to a 70-year-old woman from New York survived balamuthiasis after 
treatment with a combination of pentamidine isethionate, sulfadiazine, clarithromycin, 
fluconazole, and flucytosine (5-fluorocytosine) (Deetz et al., 2003).  
In the case of the Peruvian balamuthiasis patients with cutaneous lesions (Martínez et al., 
2010; Bravo et al., 2011), one recovered without any treatment and two others became well 
after prolonged therapy with albendazole and itraconazole. The use of multiple 
antimicrobials in treatment makes it difficult to single out one or more of the drugs that 
might be the basis for optimal therapy. Furthermore, drugs may show synergistic activities 
in vivo that are not seen in in vitro testing. In vitro studies have shown that pentamidine 
and propamidine isethionates were amoebastatic but not amoebicidal. Among other drugs 
tested with little or no activity were macrolide antibiotics, azole compounds, gramicidin, 
polymyxin B, trimethoprim, sulfamethoxazole, and a combination of trimethoprim-
sulfamethoxazole as well as amphotericin B (Maciver, 2007; Visvesvara et al., 2007). 
Recent information based on in vitro data has shown that miltefosine was able to lysed the 
amoebae. Voriconazole, however, had virtually no effect on Balamuthia (Maciver, 2007; 
Visvesvara et al., 2007). Given the problems with the diagnosis of infection and the lack of 
effective antimicrobial agents, the prognosis for patients is poor. 
3.3 Naegleria fowleri  
Few patients have survived PAM. One of these survivors, a Californian girl, was 
aggressively treated with intravenous and intrathecal amphotericin B, intravenous and 
intrathecal miconazole, and oral rifampin [2, 28]. Over a 4- year follow-up, she remained 
completely healthy and free of any neurological deficits. It was believed that amphotericin B 
and miconazole had a synergistic effect but that rifampin was without effect on the 
amoebae. Based on in vitro testing and in vivo mouse studies, amphotericin B was reported 
to be more effective against Naegleria than amphotericin B methyl ester, a water-soluble 
form of the drug. In vitro studies of phenothiazine compounds (chlorpromazine and 
trifluoperazine), which can accumulate in the CNS, were found to have inhibitory effects on 
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N. fowleri (Visvesvara et al., 2007; da Rocha-Azevedo et al., 2009). Azithromycin, a macrolide 
antimicrobial, has been shown to be effective against Naegleria both in vitro and in vivo 
(mouse model of disease). However, other macrolides (erythromycin, clarithromycin) are 
less effective. Naegleria fowleri is also sensitive to voriconazole (Marciano-Cabral and Cabral, 
2003; Visvesvara et al., 2007; da Rocha-Azevedo et al., 2009).  
3.4 Sappinia spp.  
As it has been recently reported as pathogenic to humans and other animals, no studies 
have been carried out so far regarding therapy and prognosis of this amoeba. 
 
 
Naegleria fowleri 
(PAM) 
Acanthamoeba 
(AGE) 
Balamuthia 
mandrillaris 
(BAE) 
Sappinia spp. 
Life cycle 
Three stages: 
amoeba, cyst and 
flagellate 
Two stages: amoeba 
and cyst 
Two stages: amoeba 
and cyst 
Two stages: 
amoeba and 
cyst 
Distinctive 
morphological 
features 
Vesicular nucleus; 
limacine 
movement of 
amoebae; 
flagellate stage; 
cyst with pores 
flush at the 
surface 
Vesicular nucleus; 
finger-like 
pseudopodia 
projecting from 
surface; cyst wall with 
two layers and with 
pores 
Vesicular nucleus 
with single or 
multiple nucleoli; 
amoeboid and 
‘spider-like’ 
movements in 
culture; cyst wall 
with three layers 
Presence of two 
abutting nuclei 
in amoeba and 
cyst stages 
Prodromal 
period 
Days Weeks to months Weeks to months Insufficient data 
Epidemiology 
Humans typically 
infected while 
recreating in 
warm fresh 
waters 
Infection from soil, 
water, and air; present 
in hospital 
environment (water 
taps, hydrotherapy 
pools, air conditioning 
cooling towers) 
Infection from soil, 
water, and air 
Present in soil, 
water and in 
air; originally 
identified from 
herbivore 
faeces. 
Groups at risk 
Children and 
young adults in 
good health 
Typically, 
immunocompromised 
individuals 
Immunocompetent 
(children and elderly) 
or 
immunocompromise
d individuals; 
Hispanic Americans 
Insufficient data 
Disease at 
presentation 
Headache, stiff 
neck, seizures, 
coma 
Headache, stiff neck, 
behavioural changes, 
coma 
Headache, nausea, 
seizures, stiff neck, 
hydrocephalus; sinus 
infection; nodule 
formation in 
cutaneous infections 
Headache, 
vomiting, 
photophobia, 
loss of 
consciousness; 
preceded by 
sinus infection 
Clinical course 
Fulminant 
disease; death 
within 1–2 weeks 
without treatment
Indolent subacute 
course; acute stage 
fatal in weeks 
Indolent subacute 
course; once in acute 
stage, fatal in weeks 
Insufficient data 
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Naegleria fowleri 
(PAM) 
Acanthamoeba 
(AGE) 
Balamuthia 
mandrillaris 
(BAE) 
Sappinia spp. 
Prevention 
Public health 
monitoring of 
warm, fresh-
water recreational 
sites 
Widespread in soil 
and water; in hospital 
setting, monitoring of 
water supply, 
ventilators, air 
conditioning units 
Found in soil and 
water; preventive 
measures not feasible
Insufficient 
data; organism 
found in soil; 
preventive 
measures not 
feasible 
Current therapy 
Intrathecal 
amphotericin B, 
miconazole 
Pentamidine, azole 
compounds, 
flucytosine, 
sulfadiazine 
Pentamidine, 
azithromycin, 
fluconazole, 
flucytosine 
Azithromycin, 
pentamidine, 
itraconazole, 
flucytosine 
 
Prognosis 
Fair if diagnosed 
early (within 
days); otherwise 
poor−a few 
patients have 
survived 
Poor; diagnosis is 
often 
postmortem−only a 
few patients have 
survived 
Poor; diagnosis is 
often 
postmortem−three 
patients have 
survived 
Insufficient data 
Table 1. Characteristics of FLA as causal agents of encephalitis (adapted from Visvesvara et 
al., 2007). 
3.5 Novel therapeutic approaches 
Recently, the application of siRNA in Acanthamoeba species (Lorenzo-Morales et al., 2005; 
2008; 2010) has opened a novel approach for the progress of future therapies based on 
siRNAs alone or in combination with chemical compounds. Also the use of RNAi 
moleculaes could be very powerful for the identification of novel drug targets and metabolic 
pathways in these pathogens that could be exploited for the development of new 
therapeutic agents. Recently, RNAi methodology has been successfully use in Naegleria 
fowleri (Jung et al., 2008) resulting in a reduced pathogenicity of the RNAi-treated amoebae. 
Therefore, RNAi molecules are currently presenting as very powerful tools that are waiting 
to be fully exploited in the development of new therapies against pathogenic FLA. 
4. Conclusions 
Regarding encephalitis caused by FLA, it is important to mention that because most of them 
are ultimately fatal, diagnosis of these infections is often made at autopsy, even in 
developed countries where sophisticated diagnostic facilities are readily available. 
However, in Sub-Saharan Africa and Southeast Asia, where HIV/AIDS rates are increasing, 
it is quite possible that a large number of cases have gone undetected. A similar case occurs 
in South America, where skin infections due to B. mandrillaris are a common episode in 
countries like Peru but the lack of diagnostic and treatment facilities in most areas have 
caused that most of these cases have been unnoticed as well. 
This due to a number of reasons: (1) lack of expertise to identify these pathogenic amoebae; 
(2) cultural methods and expense that prevent autopsies; and (3) an abundance of more 
prominent diseases such as HIV/AIDS, tuberculosis and malaria that consume national and 
international resources. Therefore, the actual incidence of the encephalitis caused by FLA is 
not really known although it seems that these pathogenic amoebae are emerging as 
causative agents of encephalitis worldwide. 
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